Biogen, Inc. (BIIB)
165.22
+0.80
(+0.49%)
USD |
NASDAQ |
Jan 20, 16:00
165.08
-0.14
(-0.08%)
After-Hours: 19:20
Biogen Research and Development Expense (Annual): 1.755B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| AbbVie, Inc. | 8.315B |
| Stoke Therapeutics, Inc. | 86.96M |
| Alnylam Pharmaceuticals, Inc. | 1.126B |
| Insmed, Inc. | 598.37M |